News
Latest
-
![Digital illustration of a DNA double helix strand with glowing blue and red particles against a dark background.]()
Clinical Thought Leadership
-
![Digital wall of multimedia screens with news and technology content]()
Press Releases
-
![Informative content aimed at educating the public about lung cancer, early detection methods, the importance of biomarkers, and general health tips related to cancer prevention and care.]()
Educational Articles
-
![Detailed scientific studies and findings related to lung cancer detection, biomarker research, and other relevant medical research conducted or published by Cizzle Bio or related entities.]()
Research Papers
Cizzle Bio News
Stay informed with the latest updates on Cizzle Bio's milestones, industry news, and significant events. Here, you will find:
-
![Business professionals reviewing company milestones and progress reports in lung cancer diagnostics, highlighting key achievements in medical innovation.]()
Company Milestones
Discover our key achievements and progress in developing cutting-edge lung cancer diagnostics.
-
![Digital collage of news screens showcasing the latest trends and advancements in the biotechnology field, highlighting industry news and updates.]()
Industry News
Keep up with the latest trends and advancements in the biotechnology field.
-
![Doctor and business professional shaking hands, symbolizing strategic partnerships and collaborations to enhance cancer detection efforts.]()
Collaborations and Partnerships
Learn about our strategic partnerships and collaborative efforts to enhance cancer detection.
-
![Doctor presenting at a conference, discussing significant events and advancements in healthcare and biotechnology, highlighting Cizzle Bio's impact.]()
Significant Events
Follow Cizzle Bio at conferences, scientific meetings, and industry events advancing oncology, diagnostics, and earlier cancer detection.
Cizzle Bio’s Dr. Steven Rosen Joins Cancer Research Leaders at GCRIS
Dr. Steven Rosen, Cizzle Bio’s Scientific Advisor, joined leading cancer researchers at GCRIS 2026, highlighting the expertise guiding the company’s biomarker science.
Cizzle Bio Supports Early Cancer Detection at Prevent Cancer Foundation’s 2026 Gala
Cizzle Bio sponsored the Prevent Cancer Foundation’s 2026 Annual Gala, supporting cancer prevention, early detection and better outcomes for patients.
New Peer-Reviewed Study Advances CIZ1B Blood Test for Early Lung Cancer Detection
Cizzle Bio announces new peer-reviewed research in The Journal of Applied Laboratory Medicine supporting the CIZ1B biomarker for early lung cancer detection, including 94% sensitivity and 97% negative predictive value in the early-stage cohort.
Dr. Steven Rosen, Cizzle Bio’s Scientific Advisor, joined leading cancer researchers at GCRIS 2026, highlighting the expertise guiding the company’s biomarker science.